Kieran Berry

Revenue for the 4Q was 415.2M, FLAT compared to June 30/13 Q. EPS for the 4Q was $0.61, a 22% increase from the June 30/13 Q. Operating profit for the 4Q was $98.5 million, cash flow from operations - $115.6 million. 4Q results lower than anticipated, due to softer sales in the states, partially offset by growth in international markets. Good to see that they are gaining traction with AirFit platform and the launch of Astral platform looks OK. Flat result on a bad day in the market. Should see a re-rate upon launch of Airsense 10

James Marlay

Kieran, have you had a chance to look over the Resmed results? What were your thoughts?